BioChem beats Street estimate

BioChem Pharma (BCHE; TSE:BCH) reported EPS of US$0.25 for the third quarter ended Sept. 30, beating by $0.01 the Street consensus. Revenues in the third quarter were C$85.5 million (US$56.5 million),...